SFX by Ex Libris Inc.

Title:	Preferential recognition of avian-like receptors in human influenza A H7N9 viruses
Source:	Science [0036-8075] Xu, R yr:2013

Basic

Sorry, no full text available...

Please use the document delivery service (see below)

Holding information

Holdings in library search engine ALBERT

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Fries, Louis F. "A Recombinant Viruslike Particle Influenza A (H7N9) Vaccine." The New England journal of medicine 369.26 (2013): 2564-2566.
description	2.	Horby, P. "H7N9 is a virus worth worrying about: warnings about the emergence of another influenza virus may elicit scepticism, but we should not be complacent.(WORLD VIEW: A personal take on events)." Nature 496.7446 (2013): 399-.
description	3.	Rudenko, L. "H7N9: can H7N3 live-attenuated influenza vaccine be used at the early stage of the pandemic?" Expert review of vaccines (2013): 1-4.
description	4.	Paulson, James C. "H5N1 receptor specificity as a factor in pandemic risk." Virus research 178.1 (2013): 99-113.
description	5.	Bart, Stephan A. "A Cell Culture-Derived MF59-Adjuvanted Pandemic A/H7N9 Vaccine Is Immunogenic in Adults." Science translational medicine 6.234 (2014): 234-234.
description	6.	Asl, R. "Outcome assessment of a triangular clinic as a harm reduction intervention in Rajaee-Shahr Prison, Iran." Harm reduction journal 10.1 (2013): 41-41.
description	7.	Caplan, A. "Managing the human toll caused by seasonal influenza: New York State's mandate to vaccinate or mask." JAMA: the Journal of the American Medical Association 310.17 (2013): 1797-1798.
description	8.	Lee, Raphael T. "A new piece in the puzzle of the novel avian-origin influenza a (H7N9) virus." Biology direct (2013): 26-26.
description	9.	Tubert Bitter, P. "A New Self-Controlled Case Series Method for Analyzing Spontaneous Reports of Adverse Events After Vaccination." American journal of epidemiology 178.9 (2013): 1496-1504.
description	10.	Wing, R. "Cardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes." The New England journal of medicine 369.2 (2013): 4294967295-154.
description	11.	Pica, N. "Toward a universal influenza virus vaccine: prospects and challenges." Annual Review of Medicine 64.1 (2013): 189-202.
description	12.	Watanabe, Y. "The changing nature of avian influenza A virus (H5N1)." Trends in Microbiology 20.1 (2012): 11-20.
description	13.	Perdue, Michael L. "The future of cell culture-based influenza vaccine production." Expert review of vaccines 10.8 (2011): 1183-1194.
description	14.	Stevens, J.. "Glycan microarray technologies: tools to survey host specificity of influenza viruses." Nature reviews. Microbiology 4.11 (2006): 857-864.
description	15.	Haden, M. "A vision for cannabis regulation: a public health approach based on lessons learned from the regulation of alcohol and tobacco." Open Medicine 8.2 (2014): 73-80.
description	16.	Gerstein, Hertzel C. "Do Lifestyle Changes Reduce Serious Outcomes in Diabetes?" The New England journal of medicine 369.2 (2013): 189-190.
description	17.	Dowd, Ariane M. "Do Planning and Visual Integration Difficulties Underpin Motor Dysfunction in Autism? A Kinematic Study of Young Children with Autism." Journal of autism and developmental disorders 42.8 (2011): 1539-1548.
description	18.	Gregg, Edward W. "Association of an Intensive Lifestyle Intervention With Remission of Type 2 Diabetes<alt-title>Diabetes Remission After Weight Loss Intervention</alt-title>." JAMA (Chicago, Ill.) 308.23 (2012): 2489-96.
description	19.	Feng, S. "Development and strategies of cell-culture technology for influenza vaccine." Applied microbiology and biotechnology 89.4 (2010): 893-902.
description	20.	Disney, Matthew D D. "The use of carbohydrate microarrays to study carbohydrate-cell interactions and to detect pathogens." Chemistry & biology 11.12 (2004): 1701-1707.